The current earnings forecast score of NeOnc Technologies Holdings Inc is 8.67, ranking 74 out of 385 in the Biotechnology & Medical Research industry.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
16.000
Target Price
+357.14%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
NeOnc Technologies Holdings Inc
NTHI
3
Beigene Ltd
ONC
28
argenx SE
ARGX
26
Ionis Pharmaceuticals Inc
IONS
26
IQVIA Holdings Inc
IQV
25
Insmed Inc
INSM
23
1
2
3
...
99
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
How have NeOnc Technologies Holdings IncNTHI's recent earnings per share performed?
The market expectation was USD -0.38, while NeOnc Technologies Holdings IncNTHI's earnings per share (EPS) for the previous quarter was USD -0.73. EPS for the next quarter is expected at USD -0.15.
What is the analyst rating for NeOnc Technologies Holdings Inc?
Based on the ratings of NeOnc Technologies Holdings Inc's stock from 3 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.